Genetic modification of somatic stem cells
Open Access
- 1 July 2008
- journal article
- Published by European Molecular Biology Organization in EMBO Reports
- Vol. 9 (S1), S64-S69
- https://doi.org/10.1038/embor.2008.81
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- In vivo selection of genetically modified erythroblastic progenitors leads to long-term correction of β-thalassemiaProceedings of the National Academy of Sciences of the United States of America, 2008
- LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1Science, 2003
- Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transferMolecular Genetics and Metabolism, 2003
- Stem cell transplantation for hemoglobinopathiesCurrent Opinion in Pediatrics, 2003
- Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968–99The Lancet, 2003
- Correction of ADA-SCID by Stem Cell Gene Therapy Combined with Nonmyeloablative ConditioningScience, 2002
- The cure of thalassemia by bone marrow transplantationBlood Reviews, 2002
- Primary immunodeficiency diseases: an experimental model for molecular medicineThe Lancet, 2001
- Functional requirements for phenotypic correction of murine β-thalassemia: implications for human gene therapyBlood, 2001
- Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 DiseaseScience, 2000